|
1
|
Seeber LM and Van Diest PJ: Epigenetics in
ovarian cancer. Methods Mol Biol. 863:253–269. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Meyerhardt JA, Catalano PJ, Haller DG,
Mayer RJ, Macdonald JS, Benson AB III and Fuchs CS: Impact of
diabetes mellitus on outcomes in patients with colon cancer. J Clin
Oncol. 21:433–440. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Papa V, Pezzino V, Costantino A, Belfiore
A, Giuffrida D, Frittitta L, Vannelli GB, Brand R, Goldfine ID and
Vigneri R: Elevated insulin receptor content in human breast
cancer. J Clin Invest. 86:1503–1510. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Belfiore A: The role of insulin receptor
isoforms and hybrid insulin/IGF-I receptors in human cancer. Curr
Pharm Des. 13:671–686. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartucci M, Morelli C, Mauro L, Andò S and
Surmacz E: Differential insulin-like growth factor I receptor
signaling and function in estrogen receptor (ER)-positive MCF-7 and
ER-negative MDA-MB-231 breast cancer cells. Cancer Res.
61:6747–6754. 2001.PubMed/NCBI
|
|
6
|
Miglietta A, Panno ML, Bozzo F, Gabriel L
and Bocca C: Insulin can modulate MCF-7 cell response to
paclitaxel. Cancer Lett. 209:139–145. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zou K, Ju JH and Xie H: Pretreatment with
insulin enhances anticancer functions of 5-fluorouracil in human
esophageal and colonic cancer cells. Acta Pharmacol Sin.
28:721–730. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hellawell GO, Turner GD, Davies DR,
Poulsom R, Brewster SF and Macaulay VM: Expression of the type 1
insulin like growth factor receptor is up-regulated in primary
prostate cancer and commonly persists in metastatic disease. Cancer
Res. 62:2942–2950. 2002.PubMed/NCBI
|
|
9
|
Cox ME, Gleave ME, Zakikhani M, Bell RH,
Piura E, Vickers E, Cunningham M, Larsson O, Fazli L and Pollak M:
Insulin receptor expression by human prostate cancers. Prostate.
96:33–40. 2009. View Article : Google Scholar
|
|
10
|
Law JH, Habibi G, Hu K, Masoudi H, Wang
MY, Stratford AL, Park E, Gee JM, Finlay P, Jones HE, et al:
Phosphorylated insulin-like growth factor-i/insulin receptor is
present in all breast cancer subtypes and is related to poor
survival. Cancer Res. 68:10238–10246. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
DeVita VT: Dose-response is alive and
well. J Clin Oncol. 4:1157–1159. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Minden A and Karin M: Regulation and
function of the JNK subgroup of MAP kinases. Biochim Biophys Acta.
1333:F85–104. 1997.PubMed/NCBI
|
|
13
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kyriakis JM, Banerjee P, Nikolakaki E, Dai
T, Rubie EA, Ahmad MF, Avruch J and Woodgett JR: The
stress-activated protein kinase subfamily of c-Jun kinase. Nature.
369:156–160. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li-Weber M: New therapeutic aspects of
flavones: The anticancer properties of Scutellaria and its main
active constituents Wogonin, Baicalein and Baicalin. Cancer Treat
Rev. 35:57–68. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Osborne CK, Bolan G, Monaco ME and Lippman
ME: Hormone responsive human breast cancer in long-term tissue
culture: Effect of insulin. Proc Natl Acad Sci USA. 73:pp.
4536–4540. 1976; View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Crescenzi E, Chiaviello A, Canti G, Reddi
E, Veneziani BM and Palumbo G: Low doses of cisplatin or
gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell
cycle phase-related activity accounts for synergistic outcome in
metastatic non-small cell lung cancer cells (H1299). Mol Cancer
Ther. 5:776–785. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Weston CR and Davis RJ: The JNK signal
transduction pathway. Curr Opin Genet Dev. 12:14–21. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arcidiacono B, Iiritano S, Nocera A,
Possidente K, Nevolo MT, Ventura V, Foti D, Chiefari E and Brunetti
A: Insulin resistance and cancer risk: An overview of the
pathogenetic mechanisms. Exp Diabetes Res. 2012:7891742012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Weroha SJ and Haluska P: The insulin-like
growth factor system in cancer. Endocrinol Metab Clin North Am.
41:335–350. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ichijo H: From receptors to
stress-activated MAP kinase. Oncogene. 18:6087–6093. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bogoyevitch MA: The isoform-specific
functions of the c-Jun N-terminal Kinases (JNKs): Differences
revealed by gene targeting. Bioessays. 28:923–934. 2006. View Article : Google Scholar : PubMed/NCBI
|
